STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZTS
  4. [Form 4] Zoetis Inc. Insider Trading Activity

Zoetis EVP granted RSUs and stock options

Ashton Nicholas reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ashton Nicholas reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. Executive Vice President Nicholas Ashton reported equity awards consisting of restricted stock units (RSUs) and stock options. On February 18, 2026, he received a grant of 4,148 RSUs and 16,413 stock options under the Zoetis Amended and Restated 2013 Equity and Incentive Plan.

Each RSU represents a contingent right to receive one share of Zoetis common stock. One-third of each RSU and one-third of each option vest on the first, second and third anniversaries of the grant date, subject to his continued service and certain earlier vesting events. Each option expires on the tenth anniversary of its grant date.

Positive

  • None.

Negative

  • None.
Insider Ashton Nicholas
Role Executive Vice President
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 4,148 $0.00 $0.00
Grant/Award Stock Option 16,413 $0.00 $0.00
holding Restricted Stock Unit -- -- --
holding Restricted Stock Unit -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
holding Stock Option -- -- --
Holdings After Transaction: Restricted Stock Unit — 6,779.4257 contracts for 2,631.4257 underlying shares (Direct); Stock Option — 37,017 contracts for 20,604 underlying shares (Direct)
Footnotes (15)
  1. F1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
  2. F2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
  3. F3. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
  4. F4. Not applicable.
  5. F5. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
  6. F6. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
  7. F7. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
  8. F8. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
  9. F9. Each option expires on the tenth anniversary of the date of grant.
  10. F10. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
  11. F11. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
  12. F12. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
  13. F13. Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
  14. F14. 1,930 options granted October 30, 2020 at an exercise price of $158.55 per option; 785 options granted February 10, 2021 at an exercise price of $160.62 per option; and 654 options granted February 8, 2022 at an exercise price of $201.30 per option.
  15. F15. Each option vested on the third anniversary of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Zoetis (ZTS) Executive Vice President Nicholas Ashton report?
Nicholas Ashton reported receiving new equity awards, not open-market trades. On February 18, 2026, he was granted 4,148 restricted stock units and 16,413 stock options under Zoetis’ equity and incentive plan as part of his executive compensation.

How many restricted stock units were granted to Zoetis EVP Nicholas Ashton?
Nicholas Ashton received a grant of 4,148 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Zoetis common stock, subject to vesting conditions based on his continued service and certain specified earlier-vesting events.

How many stock options did Nicholas Ashton receive from Zoetis and how do they vest?
He received 16,413 stock options on February 18, 2026. One-third of each option vests on the first, second and third anniversaries of the grant date, subject to his continued service with Zoetis and certain earlier vesting provisions.

What is the vesting schedule for Nicholas Ashton’s new Zoetis restricted stock units?
The 4,148 RSUs granted to Nicholas Ashton vest in three equal installments. One-third vests and is settled in Zoetis common shares on each of the first, second and third anniversaries of the February 18, 2026 grant date, assuming continued service.

When do Nicholas Ashton’s newly granted Zoetis stock options expire?
Each of Nicholas Ashton’s newly granted Zoetis stock options expires on the tenth anniversary of its February 18, 2026 grant date. The options vest in three equal annual installments before expiration, provided he continues serving the company.

Are Nicholas Ashton’s reported Zoetis Form 4 transactions open-market buys or sells?
The reported Form 4 activity reflects grants of RSUs and stock options, not open-market purchases or sales. The transactions are coded as awards under Zoetis’ equity and incentive plan, representing compensation rather than discretionary trading in Zoetis shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ashton Nicholas
(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY
(Street)
PARSIPPANY NJ 07054
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(1) (2) 02/18/2026 A 4,148 (3) (4) Common Stock 4,148 $0 4,148 D
Restricted Stock Unit(1) (2) (5) (4) Common Stock 2,250.4257 2,250.4257 D
Restricted Stock Unit(1) (2) (6) (4) Common Stock 381 381 D
Stock Option(7) $129.13 02/18/2026 A 16,413 (8) (9) Common Stock 16,413 $0 16,413 D
Stock Option(7) $156.64 (10) (9) Common Stock 8,642 8,642 D
Stock Option(7) $196.14 (11) (9) Common Stock 4,289 4,289 D
Stock Option(7) $162.07 (12) (9) Common Stock 4,304 4,304 D
Stock Option(13) (14) (15) (9) Common Stock 3,369 3,369(14) D
Explanation of Responses:
1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
3. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. Not applicable.
5. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
6. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
7. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
8. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
9. Each option expires on the tenth anniversary of the date of grant.
10. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
11. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
12. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
13. Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
14. 1,930 options granted October 30, 2020 at an exercise price of $158.55 per option; 785 options granted February 10, 2021 at an exercise price of $160.62 per option; and 654 options granted February 8, 2022 at an exercise price of $201.30 per option.
15. Each option vested on the third anniversary of the date of grant.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 02/19/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

Keep reading

More on ZTS

Trending in the feed

Open the live feed